MD478G2 - Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie - Google Patents

Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie

Info

Publication number
MD478G2
MD478G2 MD96-0032A MD960032A MD478G2 MD 478 G2 MD478 G2 MD 478G2 MD 960032 A MD960032 A MD 960032A MD 478 G2 MD478 G2 MD 478G2
Authority
MD
Moldova
Prior art keywords
days
day
evening
proposed method
method consists
Prior art date
Application number
MD96-0032A
Other languages
English (en)
Russian (ru)
Other versions
MD478F1 (ro
Inventor
Maria Rusu
Зинаида АНЕСТИАДИ
Константин БАБЮК
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MD96-0032A priority Critical patent/MD478G2/ro
Publication of MD478F1 publication Critical patent/MD478F1/ro
Publication of MD478G2 publication Critical patent/MD478G2/ro

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la medicină, în special la gastroenterologie.Esenţa metodei propuse constă în aceea că la regimul limitat, dietă, tratamentul cu preparate antisecretoare şi antimicrobiene suplimentar se administrează bromocriptină conform următoarei scheme: primele 3 zile câte 1,25-2,5 mg seara, în zilele a 4-6 - 1,25-2,5 mg dimineaţa şi seara, în zilele a 7-9-a - 1,25-2,5 mg de 3 ori pe zi, iar începând cu a 10-a zi - 2,5-3,75 mg de 3 ori pe zi până la dispariţia semnelor clinice ale bolii ulceroase şi normalizarea concentraţiei sporite a prolactinei serice. După aceasta doza bromocriptinei treptat se reduce: 3 zile câte 1,25-2,5 mg de 3 ori, următoarele 2-3 zile - 1,25-2,5 mg de 2 ori şi ultimele 3 zile câte 1,25-2,5 mg seara.Rezultatul tehnic al metodei propuse constă în reducerea frecvenţei recidivelor şi accelerarea vindecării ulcerelor gastroduodenale.
MD96-0032A 1996-02-20 1996-02-20 Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie MD478G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD96-0032A MD478G2 (ro) 1996-02-20 1996-02-20 Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD96-0032A MD478G2 (ro) 1996-02-20 1996-02-20 Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie

Publications (2)

Publication Number Publication Date
MD478F1 MD478F1 (ro) 1996-10-31
MD478G2 true MD478G2 (ro) 1997-05-31

Family

ID=19738790

Family Applications (1)

Application Number Title Priority Date Filing Date
MD96-0032A MD478G2 (ro) 1996-02-20 1996-02-20 Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie

Country Status (1)

Country Link
MD (1) MD478G2 (ro)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Терапевтический архив, т. 62, № 2, 1990 г., Медицина, М., А. С. Логинов "Язвенная болезнь", с. 7-28. *
Терапевтический архив, т. 63, № 2,1991 г., Медицина, М., П.Я Григорьев, В.А. Исаков "Этиологические и патогенетические подходы к лечению язвенной болезни", c. 30. *

Also Published As

Publication number Publication date
MD478F1 (ro) 1996-10-31

Similar Documents

Publication Publication Date Title
UA37244C2 (uk) Спосіб лікування або профілактики клінічних розладів, виліковних прогестероном, у пацієнтів жіночої статі
Rabbani et al. Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae
WEISER et al. Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial
UA41995C2 (uk) Лікарська форма азитроміцину з контрольованим вивільненням ( варіанти ), спосіб її введення, спосіб її виготовлення і спосіб лікування інфекційних захворювань ссавців з її використанням ( варіанти )
AU3827989A (en) Method of treatment for autoimmune diseases
EP0377272A3 (en) Use of nalmefene or naltrexone in the manufacture of a medicament for the treatment of inflammation in an arthritic disease or associated inflammatory diseases
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
Sullivan et al. Enkephalin in peripheral neuroendocrine tumours
GR3034186T3 (en) 3,4-diarylchromans for treatment of dermatitis
AU623189B2 (en) Method of treatment for interstitial cystitis
ATE229809T1 (de) Verwendung von magnesium enthaltenden verbindungen zur behandlung oder prophylaxe von krebs- und autoimmunkrankheiten
EP1294375A4 (en) METHOD FOR THE TREATMENT OF SEBORRHOIC DERMATITIS
FR2437834A1 (fr) Compositions pharmaceutiques a base de l-serine ou de glycine
MD478G2 (ro) Procedeu de tratament al bolii ulceroase la femei cu hiperprolactinemie
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
Cerklewski Influence of dietary magnesium on fluoride bioavailability in the rat
US5766640A (en) Simutaneous treatment of osteoporosis and hypertension
Brunner et al. Treatment of duodenal ulcer with pirenzepine and cimetidine.
Mazure Comparative efficacy of misoprostol and cimetidine in the treatment of acute duodenal ulcer: Results of major studies
Mungavin et al. Comparison of two dosage regimens of trazodone(molipaxin) in the treatment of depression. A multicentre general practice study.
Johannessen et al. 1-and 4-week cimetidine treatment for duodenal ulcer
Beckingham et al. Acute thrombocytopenia after De-Nol.
SU1109167A1 (ru) Способ профилактики острых стрессовых зв желудка и двенадцатиперстной кишки
CN114652762A (zh) 一种用于口腔溃疡的药物组合物及其制备方法
Henneman Prevention of acute mountain sickness by dexamethasone: Johnson TS, Rock PB, Fulco CS, et al N Engl J Med 310: 683–686 Mar 1984

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20160220